These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3801283)

  • 21. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
    Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
    Kelsen DP; Fein R; Coonley C; Heelan R; Bains M
    Cancer Treat Rep; 1986 Feb; 70(2):255-9. PubMed ID: 3948190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].
    Gatzemeier U; Zschaber R; Hossfeld DK; Radenbach D
    Onkologie; 1984 Oct; 7(5):308-15. PubMed ID: 6392971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.
    Nakano T; Ikegami H; Nakamura S; Kawase T; Nishikawa H; Yokota S; Yoshida M; Tachibana T; Igarashi T; Komuta K; Higashino K
    Br J Cancer; 1996 May; 73(9):1096-100. PubMed ID: 8624270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trial.
    Dinwoodie WR; Bartolucci AA; Lyman GH; Velez-Garcia E; Martelo OJ; Sarma PR
    Cancer Treat Rep; 1986 Feb; 70(2):267-70. PubMed ID: 2418969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Remarkable effect of vindesine sulfate (VDS) in the treatment of metachronous lung metastasis of esophageal cancer--a case report].
    Hasegawa M; Suzuki S; Miyashita K; Suzuki T; Tanaka O; Sasaki K; Muto T
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):163-6. PubMed ID: 3337524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung cancer found in a patient with absence of the inferior vena cava associated with a left superior vena cava.
    Kodama K; Doi O; Higashiyama M; Yokouchi H; Kuriyama K
    J Cardiovasc Surg (Torino); 1994 Jun; 35(3):253-5. PubMed ID: 8040176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
    Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of a vindesine-resistant human small-cell lung cancer cell line.
    Ohta S; Nishio K; Kubo S; Nishio M; Ohmori T; Takahashi T; Saijo N
    Br J Cancer; 1993 Jul; 68(1):74-9. PubMed ID: 8391305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of platinum-drug cytotoxicity in a human head and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin B and phospholipase A2-II.
    Ferguson PJ; Currie C; Vincent MD
    Drug Metab Dispos; 1999 Dec; 27(12):1399-405. PubMed ID: 10570020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy for older people with non-small cell lung cancer.
    Kanda A; Yanai M; Hirai H; Suzuki T; Sasaki H
    J Am Geriatr Soc; 2000 Nov; 48(11):1536-7. PubMed ID: 11083343
    [No Abstract]   [Full Text] [Related]  

  • 34. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug.
    Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Feb; 43(2):808-13. PubMed ID: 6848194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
    Masuda N
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative chemotherapy in localized cancer of the esophagus with cis-platinum, vindesine and bleomycin.
    Schlag P; Herrmann R; Fritze D; Buhr H; Herfarth C; Schettler G
    Prog Clin Biol Res; 1985; 201():253-8. PubMed ID: 2419918
    [No Abstract]   [Full Text] [Related]  

  • 37. [Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
    Ohnoshi T; Hiraki S; Ueoka H; Tamura T; Kawahara S; Yonei T; Yamashita H; Ishii J; Tamai M; Egawa T
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):115-9. PubMed ID: 2827585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
    Dhingra HM; Valdivieso M; Carr DT; Chiuten DF; Farha P; Murphy WK; Spitzer G; Umsawasdi T
    J Clin Oncol; 1985 Feb; 3(2):176-83. PubMed ID: 2981982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of a multidrug-resistant phenotype in human lung xenografts.
    Mattern J; Bak M; Volm M
    Br J Cancer; 1987 Oct; 56(4):407-11. PubMed ID: 3689658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung].
    Fukabori T; Nakamura T; Kida T; Fujita Y; Goto T; Hiramori N; Fujii T; Iwasaki Y; Nakagawa M
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1213-6. PubMed ID: 2053780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.